Article

MEEI has new laser to treat diabetic retinopathy

The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy.

Boston-The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy. The pattern scan laser photocoagulator (Pascal, OptiMedica) places an array of lower energy pulses across the retina, allowing patients to receive treatment in a single session as opposed to multiple sessions.

Also, the treatment results in less inflammation and blurring of vision after treatment.

"{MEEI's] acquisition of the laser, in combination with current technologies available at the hospital, including the retinal angiograph [Spectralis, Heidelberg] and optical coherence tomography (OCT), and spectral domain OCT [Carl Zeiss Meditec], make MEEI state of the art for retina diagnosis and treatment," said Joan W. Miller, MD, MEEI chief of ophthalmology and chairwoman of ophthalmology at Harvard Medical School. "Having the best tools helps our doctors give the very best care for patients."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.